Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Accro Bioscience (suzhou) Limited

Clinical trials sponsored by Accro Bioscience (suzhou) Limited, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New pill AC-003 tested for severe transplant complication Results expected Sep 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1

Can a new pill tame ulcerative colitis Flare-Ups?

Disease control Not yet recruiting

This clinical trial is testing an experimental oral medication called AC-101 in adults with moderately to severely active ulcerative colitis (UC), a chronic inflammatory bowel disease. The study aims to see if AC-101 can help achieve clinical remission—meaning fewer symptoms and …

Phase 2 • Sponsor: Accro Bioscience (Suzhou) Limited • Aim: Disease control

Last updated Aug 19, 2026 00:00 UTC